Combination Interventions Needed to Tackle Excess Mortality From Extramedical Opioids
Excess mortality occurred as the result of a number of causes, including overdose, injuries, and both infectious and noncommunicable diseases.
Opioids
Opioid-Related Unintentional Deaths and Suicides Have Increased Since 2000
Between 2000 and 2017, unintentional deaths and suicides related to opioid use have increased substantially, whereas overall deaths from suicide have decreased.
Navigating Patient Pain Under Stricter Opioid Prescribing Laws
Investigators explored concerns with regard to opioid prescribing in compliance with new regulations in a commentary piece.
Kratom Seems Safe for Pain, Anxiety, Opioid Withdrawal
Kratom is used for symptoms of pain, anxiety, depression, and opioid withdrawal, and serious adverse events are uncommon.
Long-Term Neurodevelopmental Impacts of Prenatal Opioid Exposure
Perinatal exposure to opioids may have significant immune, neural, and behavioral effects that can alter CNS development.
Altering Default Settings in EHR Influences Opioid Prescribing
Altering the default settings in the electronic medical record can influence the quantity of opioids prescribed in an emergency department setting.
Just a Few Clinicians Account for Large Number of Opioid Scripts
A small proportion of providers account for almost half of all opioid doses and about one-quarter of opioid prescriptions.
The Link Between Opioid Receptor Function and Ethnic Disparities in Pain Management
Using μ-opioid imaging outcomes, researchers examined differences in BPND; [11C]carfentanil among healthy adults identifying as non-Hispanic black and non-Hispanic white.
Most Patients With Opioid-Related Hospitalizations Have Chronic Conditions
Since patients with chronic diseases are often prescribed opioids, researchers sought to examine the association between opioid-related hospitalization and patients with chronic disease. Since patients with chronic diseases are often prescribed opioids, researchers sought to examine the association between opioid-related hospitalization and patients with chronic disease.
FDA Panels Vote “No” on Oxycodone Extended-Release Tablets
Safety and efficacy was based on demonstration of bioequivalence to Oxycontin.
-
Loading...
-
Loading...
